| 000 | 01693 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516232239.0 | ||
| 264 | 0 | _c20151214 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1935-2735 | ||
| 024 | 7 |
_a10.1371/journal.pntd.0003101 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan den Doel, Petra | |
| 245 | 0 | 0 |
_aRecombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge. _h[electronic resource] |
| 260 |
_bPLoS neglected tropical diseases _cSep 2014 |
||
| 300 |
_ae3101 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlphavirus Infections _ximmunology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _ximmunology |
| 650 | 0 | 4 |
_aAntibodies, Viral _ximmunology |
| 650 | 0 | 4 |
_aChikungunya Fever _xprevention & control |
| 650 | 0 | 4 | _aChikungunya virus |
| 650 | 0 | 4 |
_aGlycoproteins _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aVaccines, Synthetic _ximmunology |
| 650 | 0 | 4 |
_aVaccinia virus _xgenetics |
| 650 | 0 | 4 |
_aViral Envelope Proteins _ximmunology |
| 650 | 0 | 4 |
_aViral Vaccines _ximmunology |
| 700 | 1 | _aVolz, Asisa | |
| 700 | 1 | _aRoose, Jouke M | |
| 700 | 1 | _aSewbalaksing, Varsha D | |
| 700 | 1 | _aPijlman, Gorben P | |
| 700 | 1 | _avan Middelkoop, Ingeborg | |
| 700 | 1 | _aDuiverman, Vincent | |
| 700 | 1 | _avan de Wetering, Eva | |
| 700 | 1 | _aSutter, Gerd | |
| 700 | 1 | _aOsterhaus, Albert D M E | |
| 700 | 1 | _aMartina, Byron E E | |
| 773 | 0 |
_tPLoS neglected tropical diseases _gvol. 8 _gno. 9 _gp. e3101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pntd.0003101 _zAvailable from publisher's website |
| 999 |
_c24158984 _d24158984 |
||